- Home
- QNCX vs HOVR Comparison
QNCX vs HOVR Comparison
Compare QNCX & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- HOVR
- Stock Information
- Founded
- QNCX 2012
- HOVR 2013
- Country
- QNCX United States
- HOVR Canada
- Employees
- QNCX N/A
- HOVR N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- HOVR Blank Checks
- Sector
- QNCX Health Care
- HOVR Finance
- Exchange
- QNCX Nasdaq
- HOVR Nasdaq
- Market Cap
- QNCX 85.9M
- HOVR 103.1M
- IPO Year
- QNCX 2019
- HOVR N/A
- Fundamental
- Price
- QNCX $1.65
- HOVR $2.63
- Analyst Decision
- QNCX Strong Buy
- HOVR Strong Buy
- Analyst Count
- QNCX 6
- HOVR 1
- Target Price
- QNCX $8.00
- HOVR $2.00
- AVG Volume (30 Days)
- QNCX 263.4K
- HOVR 1.3M
- Earning Date
- QNCX 11-12-2025
- HOVR 10-15-2025
- Dividend Yield
- QNCX N/A
- HOVR N/A
- EPS Growth
- QNCX N/A
- HOVR N/A
- EPS
- QNCX N/A
- HOVR 0.12
- Revenue
- QNCX N/A
- HOVR N/A
- Revenue This Year
- QNCX N/A
- HOVR N/A
- Revenue Next Year
- QNCX N/A
- HOVR N/A
- P/E Ratio
- QNCX N/A
- HOVR $21.28
- Revenue Growth
- QNCX N/A
- HOVR N/A
- 52 Week Low
- QNCX $0.69
- HOVR $0.24
- 52 Week High
- QNCX $2.45
- HOVR $2.92
- Technical
- Relative Strength Index (RSI)
- QNCX 56.09
- HOVR 65.64
- Support Level
- QNCX $1.59
- HOVR $2.38
- Resistance Level
- QNCX $1.68
- HOVR $2.87
- Average True Range (ATR)
- QNCX 0.06
- HOVR 0.26
- MACD
- QNCX 0.01
- HOVR 0.06
- Stochastic Oscillator
- QNCX 69.57
- HOVR 76.80
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.